DCP-LA-Phosphatidylinositol and Its Enantiomer Exhibit Different Bioactivities
Author(s) -
Ayako Tsuchiya,
Takeshi Kanno,
Tadashi Shimizu,
Syuhei Nakao,
Akito Tanaka,
Tomoyuki Nishizaki
Publication year - 2014
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000356670
Subject(s) - phosphatidylinositol , pi , phosphorylation , phosphatase , protein kinase c , enantiomer , inositol , chemistry , basal (medicine) , protein phosphatase 2 , microbiology and biotechnology , biochemistry , biology , stereochemistry , endocrinology , receptor , insulin
The present study was conducted to understand biochemical and biological characteristics of the phosphatidylinositol (PI) derivative 1,2-O-bis-[8-{2-(2-pentyl-cyclopropylmethyl)-cyclopropyl}-octanoyl]-Sn-glycero-3-phosphatidyl-D-1-inositol (diDCP-LA-PI) and its enantiomer 1,2-O-bis-[8-{2-(2-pentyl-cyclopropylmethyl)-cyclopropyl}-octanoyl]-Sn-glycero-3-phosphatidyl-L-1-inositol (diDCP-LA-PIe), with 8-[2-(2-pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid (DCP-LA) on the α and β position.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom